Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

IntelliPharmaCeutics International Inc Stock News

IPCIFOTC

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0999

0.19994900.00%

Pre-Market: Jun 4, 8:58 AM EDT

IntelliPharmaCeutics International Inc (IPCIF) Forecast

News

Earnings IntelliPharmaCeutics International Inc (IPCIF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest IntelliPharmaCeutics International Inc Stock News | OTC:IPCIF | Benzinga

Get the latest news on IntelliPharmaCeutics International Inc stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on IntelliPharmaCeutics International Inc performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, January 15, 2020

Nektar Slumps As FDA Panel Gives Thumbs Down To Opioid Pain Drug; Program Shelved
Shanthi Rexaline
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
Shanthi Rexaline

Sunday, January 12, 2020

The Week Ahead In Biotech: JPMorgan Healthcare Conference, FDA Panel Reviews Opioid Pain Drugs, I-Mab's IPO
Shanthi Rexaline

Wednesday, January 01, 2020

Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates
Shanthi Rexaline

Friday, December 13, 2019

Stocks That Hit 52-Week Highs On Friday
Lisa Levin

Thursday, December 12, 2019

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin

Monday, October 21, 2019

Stocks That Hit 52-Week Lows On Monday
Lisa Levin

Thursday, October 17, 2019

Stocks That Hit 52-Week Lows On Thursday
Lisa Levin

Wednesday, October 16, 2019

Stocks That Hit 52-Week Lows On Wednesday
Lisa Levin

Tuesday, October 15, 2019

Stocks That Hit 52-Week Lows On Tuesday
Lisa Levin

Friday, October 04, 2019

Intellipharmaceutics 6-K Shows Update On Purd...
Benzinga Newsdesk

Wednesday, August 28, 2019

The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved
Shanthi Rexaline

Sunday, August 25, 2019

The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend
Shanthi Rexaline

Wednesday, July 31, 2019

Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates
Shanthi Rexaline

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved